Skip to content

Aerodigestive Fistulas in Adults at the University Hospital of Strasbourg

Aerodigestive Fistulas in Adults: Management at the Strasbourg University Hospital Between 2014 and 2023

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07299513
Acronym
FAD'HUS
Enrollment
100
Registered
2025-12-23
Start date
2024-11-21
Completion date
2026-11-21
Last updated
2025-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aerodigestive Fistulas

Keywords

Aerodigestive fistulas, Endoscopic investigations, Thoracic cancer, Oncological disease, Malignant fistula

Brief summary

Acquired aerodigestive fistulas in adults are rare conditions, corresponding to a pathological communication between the digestive and respiratory tracts, requiring collaborative multidisciplinary management. Clinical manifestations are nonspecific, ranging from a simple cough to pulmonary sepsis, which can be life-threatening. Diagnosis is often multimodal, requiring radiological examinations and endoscopic investigations. The most frequent etiologies are divided into two groups: benign and malignant causes, each group representing 50% of all acquired aerodigestive fistulas. Among the benign etiologies, 75% are iatrogenic, mainly represented by complications related to orotracheal intubation. These fistulas of benign etiology most often have a favorable prognosis, amenable to surgical treatment. Conversely, the development of an aerodigestive fistula in the context of thoracic cancer marks a turning point in the evolution of the oncological disease. Indeed, the average life expectancy of patients with a malignant fistula is estimated at between 1 and 6 weeks without specific treatment. Following this palliative approach aimed at improving quality of life, multiple treatment options are available, often combined with digestive and thoracic endoscopy. The Strasbourg University Hospitals are a leading tertiary care center for these pathologies, with departments of Pulmonology, Gastroenterology, Digestive Surgery, Thoracic Surgery, Medical Intensive Care, Multipurpose Surgical Intensive Care, Bronchial Endoscopy, and Digestive Endoscopy. The centre's influence extends over the entire eastern part of the Grand Est region (Nancy, Metz, Strasbourg, Mulhouse).

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age \> 18 years at diagnosis * Diagnosis between January 1, 2014, and December 31, 2023 * Aerodigestive fistula defined by one of the following criteria: * Fistula visualized by bronchoscopy and/or digestive endoscopy * Fistula visualized by static chest imaging (CT scan or MRI) * Fistula visualized by dynamic chest imaging (barium swallow) * Hospitalization at the Strasbourg University Hospitals (HUS)

Exclusion criteria

* Explicit refusal by the patient to provide their data

Design outcomes

Primary

MeasureTime frame
Overall survival rate since diagnosisUp to 2 years

Countries

France

Contacts

Primary ContactGuillaume PAMART, MD
guillaume.pamart@chru-strasbourg.fr33 3/69/55/06/48

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026